KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Shares Outstanding (2018 - 2025)

Amneal Pharmaceuticals has reported Shares Outstanding over the past 8 years, most recently at $314.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $314.6 million for Q4 2025, up 1.51% from a year ago — trailing twelve months through Dec 2025 was $314.6 million (up 1.51% YoY), and the annual figure for FY2025 was $314.6 million, up 1.51%.
  • Shares Outstanding for Q3 2025 was $314.3 million at Amneal Pharmaceuticals, roughly flat from $314.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AMRX hit a ceiling of $314.3 million in Q3 2025 and a floor of $149.2 million in Q2 2021.
  • Median Shares Outstanding over the past 5 years was $152.1 million (2021), compared with a mean of $217.5 million.
  • Biggest five-year swings in Shares Outstanding: fell 1.91% in 2021 and later surged 103.46% in 2024.
  • Amneal Pharmaceuticals' Shares Outstanding stood at $152.1 million in 2021, then changed by 0.0% to $152.1 million in 2022, then soared by 101.53% to $306.6 million in 2023, then rose by 1.08% to $309.9 million in 2024, then rose by 1.51% to $314.6 million in 2025.
  • The last three reported values for Shares Outstanding were $314.6 million (Q4 2025), $314.3 million (Q3 2025), and $314.0 million (Q2 2025) per Business Quant data.